Table 1.
Age-standardized incidence rates (per 100,000 person-years) of ovarian cancer for 2008–2012¶, by age groups
| Country | Population coverage (million) | Period | 24–49 years | 50–74 years | |||
|---|---|---|---|---|---|---|---|
| Start | End | Cases | ASR | Cases | ASR | ||
| Asia | |||||||
| China (Shanghai) | 3.1 | 1988 | 2012 | 353 | 6.2 | 1143 | 19.2 |
| India (Chennai) | 2.3 | 1983 | 2012 | 303 | 6.9 | 498 | 25.7 |
| Israel† | 3.9 | 1963 | 2012 | 313 | 5.4 | 1093 | 28.0 |
| Japan‡ | 6.6 | 1978 | 2010 | 577 | 8.8 | 1454 | 23.2 |
| Philippines (Manila) | 3.3 | 1983 | 2012 | 631 | 11.4 | 838 | 37.6 |
| Thailand (Chiang Mai) | 0.8 | 1983 | 2012 | 111 | 6.9 | 180 | 17.6 |
| Australia/ New Zealand | |||||||
| Australia‡ | 8.6 | 1983 | 2012 | 865 | 5.4 | 2894 | 25.5 |
| New Zealand† | 2.2 | 1983 | 2012 | 249 | 6.1 | 799 | 28.3 |
| Central and South America | |||||||
| Colombia (Cali) | 1.2 | 1983 | 2012 | 146 | 6.6 | 273 | 24.9 |
| Costa Rica† | 2.2 | 1982 | 2011 | 160 | 4.9 | 229 | 15.5 |
| Ecuador (Quito) | 0.8 | 1985 | 2012 | 79 | 5.5 | 153 | 23.4 |
| North America | |||||||
| Canada‡ | 13.1 | 1983 | 2012 | 1726 | 6.8 | 5111 | 28.3 |
| United States‡: Black | 2.0 | 1978 | 2012 | 163 | 4.5 | 504 | 25.1 |
| United States‡: White | 10.8 | 1341 | 6.9 | 4744 | 32.0 | ||
| Eastern Europe | |||||||
| Belarus† | 5.1 | 1983 | 2012 | 1404 | 14.8 | 2775 | 37.2 |
| Slovakia† | 2.8 | 1971 | 2010 | 304 | 10.0 | 899 | 38.5 |
| Northern Europe | |||||||
| Denmark† | 2.8 | 1953 | 2012 | 311 | 6.1 | 1670 | 38.9 |
| Estonia† | 0.7 | 1983 | 2012 | 111 | 9.1 | 440 | 38.2 |
| Lithuania† | 1.7 | 1988 | 2012 | 436 | 13.7 | 1171 | 44.9 |
| Norway† | 2.4 | 1953 | 2012 | 255 | 5.8 | 1259 | 38.5 |
| United Kingdom (Scotland) | 2.7 | 1978 | 2012 | 336 | 6.6 | 1400 | 34.3 |
| Southern Europe | |||||||
| Croatia† | 2.3 | 1988 | 2012 | 437 | 10.9 | 1442 | 40.4 |
| Italy‡ | 1.5 | 1988 | 2012 | 190 | 7.2 | 645 | 30.9 |
| Slovenia† | 1.0 | 1983 | 2012 | 164 | 8.4 | 473 | 30.5 |
| Spain‡ | 3.0 | 1988 | 2010 | 241 | 6.7 | 648 | 27.1 |
| Western Europe | |||||||
| France‡ | 3.0 | 1983 | 2011 | 243 | 5.7 | 958 | 28.6 |
| Switzerland‡ | 1.0 | 1988 | 2012 | 79 | 4.2 | 400 | 29.7 |
Costa Rica (2008–2011); France (2008–2011); Japan (2008–2010); Slovakia (2008–2010); Spam (2008–2010)
National cancer registry
Australia - New South Wales, Tasmania, South Australia, Victoria, and Western Australia; Canada excludes Nunavut, Quebec and Yukon; France - Bas-Rhin, Calvados, Doubs, Haut-Rhin, Herault, Isere, and Somme; Italy - Modena, Parma, Ragusa, and Romagna; Japan - Miyagi, Nagasaki, and Osaka; Spain - Basque Country, Granada, Murcia, Navarra and Tarragona; Swi tzerland - Geneva, Neuchatel, St. Gall-Appenzell, and Vaud; United States - Georgia, Greater California, Idaho, Kentucky, Louisiana, Massachusetts, New York, Utah and Wisconsin (SEER-9)